Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Future cancer research priorities in the USA: a Lancet Oncology Commission.

Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A.

Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31. Review.

2.

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.

Alexander BM, Ba S, Berger MS, Berry DA, Cavenee WK, Chang SM, Cloughesy TF, Jiang T, Khasraw M, Li W, Mittman R, Poste GH, Wen PY, Yung WKA, Barker AD; GBM AGILE Network.

Clin Cancer Res. 2018 Feb 15;24(4):737-743. doi: 10.1158/1078-0432.CCR-17-0764. Epub 2017 Aug 16. Review.

3.

The national biomarker development alliance: confronting the poor productivity of biomarker research and development.

Poste G, Compton CC, Barker AD.

Expert Rev Mol Diagn. 2015 Feb;15(2):211-8. doi: 10.1586/14737159.2015.974561. Epub 2014 Nov 25. Review.

PMID:
25420639
4.

The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic.

Barker AD, Compton CC, Poste G.

Biomark Med. 2014;8(6):873-6. doi: 10.2217/bmm.14.52. No abstract available.

5.

Genome editing of mouse fibroblasts by homologous recombination for sustained secretion of PDGF-B and augmentation of wound healing.

Barker JC, Barker AD, Bills J, Huang J, Wight-Carter M, Delgado I, Noble DL, Huang LJ, Porteus MH, Davis KE.

Plast Reconstr Surg. 2014 Sep;134(3):389e-401e. doi: 10.1097/PRS.0000000000000427.

PMID:
25158716
6.

Opening up to precompetitive collaboration.

Altshuler JS, Balogh E, Barker AD, Eck SL, Friend SH, Ginsburg GS, Herbst RS, Nass SJ, Streeter CM, Wagner JA.

Sci Transl Med. 2010 Oct 6;2(52):52cm26. doi: 10.1126/scitranslmed.3001515.

PMID:
20926831
7.

The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.

Ptak K, Farrell D, Panaro NJ, Grodzinski P, Barker AD.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Sep-Oct;2(5):450-60. doi: 10.1002/wnan.98.

PMID:
20552623
8.

International network of cancer genome projects.

International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MM, Knoppers BM, Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SO, Joly Y, Kato K, Kennedy KL, Nicolás P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C, Chin L, Clément B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN, Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R, Scarpa A, Shibata T, van de Vijver M, Futreal PA, Aburatani H, Bayés M, Botwell DD, Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, López-Otín C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS, Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE, Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell PJ, Flicek P, Getz G, Guigó R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang T, Jones SM, Li Q, López-Bigas N, Luo R, Muthuswamy L, Ouellette BF, Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP, Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler DA, Wu H, Zhao S, Zhou G, Stein LD, Guigó R, Hubbard TJ, Joly Y, Jones SM, Kasprzyk A, Lathrop M, López-Bigas N, Ouellette BF, Spellman PT, Teague JW, Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SO, Futreal PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ, Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J, Yung CK, Cros A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M, Chalmers DR, Hasel KW, Joly Y, Kaan TS, Kennedy KL, Knoppers BM, Lowrance WW, Masui T, Nicolás P, Rial-Sebbag E, Rodriguez LL, Vergely C, Yoshida T, Grimmond SM, Biankin AV, Bowtell DD, Cloonan N, deFazio A, Eshleman JR, Etemadmoghadam D, Gardiner BB, Kench JG, Scarpa A, Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger S, Tsao MS, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA, Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I, Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhlén M, Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA, Birney E, Borg A, Børresen-Dale AL, Caldas C, Foekens JA, Martin S, Reis-Filho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van de Vijver M, van't Veer L, Calvo F, Birnbaum D, Blanche H, Boucher P, Boyault S, Chabannon C, Gut I, Masson-Jacquemier JD, Lathrop M, Pauporté I, Pivot X, Vincent-Salomon A, Tabone E, Theillet C, Thomas G, Tost J, Treilleux I, Calvo F, Bioulac-Sage P, Clément B, Decaens T, Degos F, Franco D, Gut I, Gut M, Heath S, Lathrop M, Samuel D, Thomas G, Zucman-Rossi J, Lichter P, Eils R, Brors B, Korbel JO, Korshunov A, Landgraf P, Lehrach H, Pfister S, Radlwimmer B, Reifenberger G, Taylor MD, von Kalle C, Majumder PP, Sarin R, Rao TS, Bhan MK, Scarpa A, Pederzoli P, Lawlor RA, Delledonne M, Bardelli A, Biankin AV, Grimmond SM, Gress T, Klimstra D, Zamboni G, Shibata T, Nakamura Y, Nakagawa H, Kusada J, Tsunoda T, Miyano S, Aburatani H, Kato K, Fujimoto A, Yoshida T, Campo E, López-Otín C, Estivill X, Guigó R, de Sanjosé S, Piris MA, Montserrat E, González-Díaz M, Puente XS, Jares P, Valencia A, Himmelbauer H, Quesada V, Bea S, Stratton MR, Futreal PA, Campbell PJ, Vincent-Salomon A, Richardson AL, Reis-Filho JS, van de Vijver M, Thomas G, Masson-Jacquemier JD, Aparicio S, Borg A, Børresen-Dale AL, Caldas C, Foekens JA, Stunnenberg HG, van't Veer L, Easton DF, Spellman PT, Martin S, Barker AD, Chin L, Collins FS, Compton CC, Ferguson ML, Gerhard DS, Getz G, Gunter C, Guttmacher A, Guyer M, Hayes DN, Lander ES, Ozenberger B, Penny R, Peterson J, Sander C, Shaw KM, Speed TP, Spellman PT, Vockley JG, Wheeler DA, Wilson RK, Hudson TJ, Chin L, Knoppers BM, Lander ES, Lichter P, Stein LD, Stratton MR, Anderson W, Barker AD, Bell C, Bobrow M, Burke W, Collins FS, Compton CC, DePinho RA, Easton DF, Futreal PA, Gerhard DS, Green AR, Guyer M, Hamilton SR, Hubbard TJ, Kallioniemi OP, Kennedy KL, Ley TJ, Liu ET, Lu Y, Majumder P, Marra M, Ozenberger B, Peterson J, Schafer AJ, Spellman PT, Stunnenberg HG, Wainwright BJ, Wilson RK, Yang H.

Nature. 2010 Apr 15;464(7291):993-8. doi: 10.1038/nature08987. Erratum in: Nature. 2010 Jun 17;465(7300):966. Himmelbaue, Heinz [corrected to Himmelbauer, Heinz]; Gardiner, Brooke A [corrected to Gardiner, Brooke B]; Cross, Anthony [corrected to Cros, Anthony].

9.

Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer.

Farrell D, Alper J, Ptak K, Panaro NJ, Grodzinski P, Barker AD.

ACS Nano. 2010 Feb 23;4(2):589-94. doi: 10.1021/nn100073g.

PMID:
20175564
10.

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.

Barker AD, Sigman CC, Kelloff GJ, Hylton NM, Berry DA, Esserman LJ.

Clin Pharmacol Ther. 2009 Jul;86(1):97-100. doi: 10.1038/clpt.2009.68. Epub 2009 May 13.

PMID:
19440188
11.
12.

Site-specific management of nematodes pitfalls and practicalities.

Evans K, Webster RM, Halford PD, Barker AD, Russell MD.

J Nematol. 2002 Sep;34(3):194-9.

13.

Evaluation of PCR, IEF and ELISA techniques for the detection and identification of potato cyst nematodes from field soil samples in England and Wales.

Ibrahim SK, Minnis ST, Barker AD, Russell MD, Haydock PP, Evans K, Grove IG, Woods SR, Wilcox A.

Pest Manag Sci. 2001 Nov;57(11):1068-74.

PMID:
11721525
14.

Report from THE MARCH Research Task Force. September 25-26, 1998.

Sigal EV, Barker AD.

Cancer Res. 1998 Dec 1;58(23):5590-627. No abstract available.

15.

Effects of thymosin on cytotoxicity and virus production in AKR mice.

Barker AD, Dennis AJ, Moore VS, Rice JM.

Ann N Y Acad Sci. 1979;332:70-80.

PMID:
294835
16.

Inactivity of DL-amygdalin against human breast and colon tumor xenografts in athymic (nude) mice.

Ovejera AA, Houchens DP, Barker AD, Venditti JM.

Cancer Treat Rep. 1978 Apr;62(4):576-8. No abstract available.

PMID:
418876
17.

Chemotherapy of human tumor xenografts in genetically athymic mice.

Ovejera AA, Houchens DP, Barker AD.

Ann Clin Lab Sci. 1978 Jan-Feb;8(1):50-6.

PMID:
623430
18.

In vivo studies of differentiation of thymus-derived leukemic cells.

Barker AD, Waksal SD.

Ann N Y Acad Sci. 1975 Feb 28;249:484-91. No abstract available.

PMID:
1055575
20.

Therapeutic and immunologic effects of iodoacetate in mature AKR mice.

Rheins MS, Barker AD.

Experientia. 1973 Apr 15;29(4):476-7. No abstract available.

PMID:
4575260
21.

The effect of rabbit anti-mouse brain-associated theta serum on the immunologic responsiveness of AKR mice.

Barker AD, Rheins MS, Pierre RL.

Cell Immunol. 1973 Apr;7(1):85-91. No abstract available.

PMID:
4571881
22.

Immunologic responsiveness of young AKR mice to iodoacetate and to iodoacetate-treated tumor cells.

Barker AD, Rheins MS, Davis GW, Wilson HE.

Immunol Commun. 1973;2(4):343-52. No abstract available.

PMID:
4583065
23.

Interferon induction in normal leukemic human lymphocyte cultures by tilorone hydrochloride.

Dennis AJ, Wilson HE, Barker AD, Rheins MS.

Proc Soc Exp Biol Med. 1972 Dec;141(3):782-5. No abstract available.

PMID:
4345706
24.

Therapeutic effects of a series of non-viral interferon inducers on a viral-induced leukemia.

Rheins MS, Barker AD, Wilson HE.

Can J Microbiol. 1971 Oct;17(10):1259-65. No abstract available.

PMID:
4108803
25.

Amelioration of friend virus leukemia by sequential administration of viral and nonviral interferon inducers.

Barker AD, Rheins MS, Wilson HE.

Proc Soc Exp Biol Med. 1971 Jul;137(3):981-7. No abstract available.

PMID:
5105377
26.

Studies on human adrenal steroids. I. The effect of corticotropin on components of the free and conjugated plasma C21 adrenal steroid fractions.

SOUTHCOTT CM, GANDOSSI SK, BARKER AD, BANDY HE, MCINTOSH H, DARRACH M.

Can J Biochem Physiol. 1956 Mar;34(2):146-57. No abstract available.

PMID:
13304735

Supplemental Content

Loading ...
Support Center